Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial – JAMA Editorial: Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19 – JAMA   Commentary on Twitter Intermediate-dose prophylactic enoxaparin (1 mg/kg/d) had […]

The post RCT: Intermediate-dose enoxaparin (1 mg/kg/d) not better than standard-dose prophylactic anticoagulation in patients with Covid-19 admitted to the intensive care unit appeared first on Links Medicus.